Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Stock
Equities
300760
CNE100003G67
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 199.82 CNY | +2.07% |
|
-1.27% | -21.64% |
| Capitalization | 242B 34.25B 29.18B 27.26B 25.65B 47.22B 3,102B 51.58B 318B 123B 1,462B 129B 126B 5,336B | P/E ratio 2025 * |
25.3x | P/E ratio 2026 * | 21.1x |
|---|---|---|---|---|---|
| Enterprise value | 222B 31.41B 26.76B 25B 23.52B 43.3B 2,845B 47.31B 292B 113B 1,341B 118B 115B 4,893B | EV / Sales 2025 * |
6.46x | EV / Sales 2026 * | 5.54x |
| Free-Float |
42.59% | Yield 2025 * |
2.64% | Yield 2026 * | 3.04% |
| 1 day | +2.07% | ||
| 1 week | -1.27% | ||
| Current month | -2.05% | ||
| 1 month | -4.02% | ||
| 3 months | -17.08% | ||
| 6 months | -15.55% | ||
| Current year | -21.64% |
| 1 week | 194.51 |  | 204.75 |
| 1 month | 191.78 | | 209.67 |
| Current year | 191.78 | | 267.1 |
| 1 year | 191.78 | | 267.1 |
| 3 years | 191.78 | | 353 |
| 5 years | 191.78 | | 503.51 |
| 10 years | 58.56 | | 503.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Wu
CEO | Chief Executive Officer | 53 | 2020-11-16 |
Yun Zhao
DFI | Director of Finance/CFO | 42 | 2019-11-14 |
Yan Mei Guo
PRN | Corporate Officer/Principal | 62 | 2021-04-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Hang Xu
CHM | Chairman | 63 | 1999-01-24 |
Xi Ting Li
CHM | Chairman | 74 | 2001-12-17 |
Ming He Cheng
BRD | Director/Board Member | 64 | 2017-01-04 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 6.79% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.07% | -1.27% | -25.79% | -36.66% | 34.25B | |
| -1.14% | -0.09% | +9.01% | +0.82% | 215B | |
| -0.92% | -5.74% | -0.44% | +98.04% | 192B | |
| -2.60% | +0.04% | -3.48% | -17.24% | 160B | |
| +0.90% | -5.07% | +2.39% | +96.44% | 137B | |
| +0.98% | +1.33% | -18.05% | -12.42% | 57.67B | |
| -1.38% | -3.61% | +12.32% | +10.30% | 48.21B | |
| -2.23% | -3.99% | -0.87% | -10.08% | 39.54B | |
| -2.43% | -1.76% | +2.85% | - | 38.25B | |
| -0.05% | -1.67% | +4.02% | +14.20% | 36.77B | |
| Average | -0.68% | -2.07% | -1.81% | +15.94% | 95.91B | |
| Weighted average by Cap. | -0.87% | -2.29% | +0.54% | +30.57% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 34.33B 4.87B 4.15B 3.87B 3.64B 6.71B 441B 7.33B 45.2B 17.53B 208B 18.26B 17.88B 758B | 39.18B 5.55B 4.73B 4.42B 4.16B 7.66B 503B 8.36B 51.59B 20.01B 237B 20.84B 20.4B 865B |
| Net income | 9.59B 1.36B 1.16B 1.08B 1.02B 1.87B 123B 2.05B 12.63B 4.9B 58.04B 5.1B 4.99B 212B | 11.46B 1.62B 1.38B 1.29B 1.22B 2.24B 147B 2.45B 15.09B 5.85B 69.36B 6.1B 5.97B 253B |
| Net Debt | -20.03B -2.84B -2.42B -2.26B -2.13B -3.91B -257B -4.27B -26.37B -10.23B -121B -10.65B -10.43B -442B | -24.68B -3.5B -2.98B -2.78B -2.62B -4.82B -317B -5.27B -32.5B -12.61B -149B -13.13B -12.85B -545B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 199.82 ¥ | +2.07% | 11,203,340 |
| 25-12-11 | 195.77 ¥ | -1.13% | 5,672,846 |
| 25-12-10 | 198.00 ¥ | -0.36% | 5,134,463 |
| 25-12-09 | 198.71 ¥ | -0.67% | 5,740,402 |
| 25-12-08 | 200.05 ¥ | -1.16% | 6,107,154 |
End-of-day quote Shenzhen S.E., December 11, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300760 Stock
Select your edition
All financial news and data tailored to specific country editions
